Patent · US Active

Genetically modified cell and process for use of said cell

US9309546B2 · kind B2 · utility

2Cited by
0References
22Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 7, 2012
Grant dateApr 12, 2016
Priority date
Expiry dateSep 22, 2032

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Y102/01
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The present invention relates to the field of biotransformation of furanic compounds. More particular the present invention relates to novel genetically modified cells with improved characteristics for biocatalytic transformation of furanic compounds and a vector suitable for the genetic modification of a host cell. Further aspects of the invention are aimed at processes for biotransformation of 5-(hydroxymethyl)furan-2-carboxylic acid (HMF-acid) and its precursors with the use of the cell according to the invention.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.